Melinta, bouncing back from bankruptcy, lands FDA approval for speedy skin infection fighter

Melinta, bouncing back from bankruptcy, lands FDA approval for speedy skin infection fighter

Source: 
Fierce Pharma
snippet: 

Antibiotic biotechs often struggle to turn their products into commercial triumphs, and that's certainly been the case for New Haven, Connecticut-based Melinta Therapeutics, which ultimately filed for bankruptcy in late 2019. But Melinta hopes its newly minted drug can become an exception, thanks to a convenience edge over rivals.